JBALX
Price
$51.00
Change
+$0.17 (+0.33%)
Updated
Oct 17 closing price
Net Assets
28.02B
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

JBALX vs RLBCX

Header iconJBALX vs RLBCX Comparison
Open Charts JBALX vs RLBCXBanner chart's image
Janus Henderson Balanced I
Price$51.00
Change+$0.17 (+0.33%)
VolumeN/A
Net Assets28.02B
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
JBALX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
JBALX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBALX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 265B vs. JBALX (28B). JBALX pays higher dividends than RLBCX: JBALX (1.73) vs RLBCX (1.49). JBALX was incepted earlier than RLBCX: JBALX (16 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than JBALX (0.66). JBALX is a more actively managed with annual turnover of: 76.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JBALX: RLBCX (250) vs JBALX (1000000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. JBALX (7.53). RLBCX (40.24) and JBALX (39.27) have equivalent 5 years return.
JBALXRLBCXJBALX / RLBCX
Total Expense Ratio0.660.8974%
Annual Report Gross Expense Ratio0.660.8974%
Fund Existence16 years23 years-
Gain YTD12.98914.36490%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets28B265B11%
Annual Yield % from dividends1.731.49116%
Returns for 1 year7.538.3490%
Returns for 3 years47.6149.2697%
Returns for 5 years39.2740.2498%
Returns for 10 years101.5872.18141%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBM3.520.07
+2.03%
Psyence Biomedical Ltd
CVGW23.810.14
+0.59%
Calavo Growers
SWK67.85-0.06
-0.09%
Stanley Black & Decker
IQ2.03-0.03
-1.46%
iQIYI
PMVP1.40-0.04
-2.78%
PMV Pharmaceuticals